STOCK TITAN

Apollo Endosurgery to Participate in the Cowen Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Apollo Endosurgery (NASDAQ:APEN) will host investor meetings on March 7-8, 2022, during the Cowen Healthcare Conference. CEO Chas McKhann and CFO Jeff Black will participate in a fireside chat on March 7 at 12:50 PM ET, available via webcast on their website. Apollo specializes in minimally invasive medical devices for gastrointestinal and bariatric procedures, with products offered in over 75 countries. Their innovative solutions aim to reduce healthcare costs and complications.

Positive
  • None.
Negative
  • None.

AUSTIN, TX / ACCESSWIRE / March 2, 2022 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in minimally invasive medical devices for gastrointestinal and bariatric procedures, today announced that Chas McKhann, CEO, and Jeff Black, CFO, will host investor meetings March 7-8, 2022 as part of the Cowen Healthcare Conference, taking place virtually.

As part of the conference event, management will participate in a fireside chat hosted by Cowen at 12:50 pm Eastern Time on Monday, March 7, 2022. A webcast of the fireside chat will be available on the Investor Relations section of the Apollo Endosurgery website, www.apolloendo.com.

For more information about scheduling a one-on-one meeting with management, please contact Matt Kreps, Investor Relations for Apollo Endosurgery, at mkreps@darrowir.com.

About Apollo Endosurgery, Inc.

Apollo Endosurgery, Inc. is a medical technology company focused on development of next-generation, less invasive devices to advance therapeutic endoscopy designed to treat a variety of gastrointestinal conditions including closure of gastrointestinal defects, managing gastrointestinal complications and the treatment of obesity. Apollo's device-based therapies are an alternative to invasive surgical procedures, thus lowering complication rates and reducing total healthcare costs. Apollo's products are offered in over 75 countries today and include the X-Tack™ Endoscopic HeliX Tacking System, the OverStitch™ Endoscopic Suturing System, the OverStitch Sx™ Endoscopic Suturing System, and the ORBERA® Intragastric Balloon.

Apollo's common stock is traded on NASDAQ Global Market under the symbol "APEN". For more information regarding Apollo Endosurgery, go to: www.apolloendo.com.

Contact:

Apollo Endosurgery, Inc.
Jeff Black, 512-279-5126
investor-relations@apolloendo.com

Darrow Associates Investor Relations
Matt Kreps, 214-597-8200
mkreps@darrowir.com

SOURCE: Apollo Endosurgery, Inc.



View source version on accesswire.com:
https://www.accesswire.com/691066/Apollo-Endosurgery-to-Participate-in-the-Cowen-Healthcare-Conference

FAQ

When is Apollo Endosurgery participating in the Cowen Healthcare Conference?

Apollo Endosurgery will participate in the Cowen Healthcare Conference on March 7-8, 2022.

Who will represent Apollo Endosurgery at the conference?

CEO Chas McKhann and CFO Jeff Black will represent Apollo Endosurgery at the conference.

What time is Apollo's fireside chat during the Cowen Healthcare Conference?

Apollo's fireside chat is scheduled for March 7, 2022, at 12:50 PM Eastern Time.

Where can I watch the Apollo Endosurgery fireside chat?

The fireside chat will be available via webcast on the Investor Relations section of Apollo's website.

What does Apollo Endosurgery specialize in?

Apollo Endosurgery specializes in minimally invasive medical devices for gastrointestinal and bariatric procedures.

In how many countries does Apollo Endosurgery offer its products?

Apollo Endosurgery offers its products in over 75 countries.

APEN

NASDAQ:APEN

APEN Rankings

APEN Latest News

APEN Stock Data

579.72M
55.25M
4.29%
63.41%
0.97%
Medical Devices
Healthcare
Link
United States
Austin